Talk to a public procurement expert
company logo

Licitaciones a

Learn about 's profile as a public procurement awardee.

Tenders

1474
Awarded: 1468
In progress: 0
Unawarded: 0

Budgets

386.559.824 €
Awarded amount: 375.163.773 €
Minor contracts: 14.083.550 €
Estimated value: 576.114.910 €

Averages

262.787 €
Discount rate: 0,4 %
Number of bidders: 1,0
Number of lots: 45,0

Organizations

34
Successful bidders: 1
Minor contracts: 1332

View complete and updated information

To access all detailed and updated information about this tender, access our Tendios platform.

Access Tendios

Top 5 Budgets

CONTRACT OBJECTBASE BUDGETDETAILS

Acord marc del subministrament del medicament omalizumab...

88.054.091,7 € View more

Suministro de medicamentos de uso humano ii (exclusivos) basado en el acuerdo ma...

51.512.575,8 € View more

CBAM del AM con CONTR 2022 206734 (PNAMSP 135/2022) - NOVARTIS FARMACÉUTICA, S.A...

26.800.000 € View more

Suministro de ofatumumab, medicamento de uso humano tipo ii (exclusivos), con de...

14.713.574,34 € View more

Suministro de ribociclib, medicamento de uso humano tipo ii (exclusivos), con de...

14.713.574,34 € View more

Latest tenders won by - Mayo 2026

Be the first to know about all tenders to in the last 12 months.

🔕 No tenders available in deadline

Create custom alert

Explore More Related Content

🏛️

Contracting Organizations

Discover the public organizations this company has worked with and their main contracts.

View organizations
📍

Tenders by Location

Explore the tenders available in Spain where this company could participate.

View tenders in Spain
🏢

Specialization Sectors

Learn about the sectors where this company has more experience and success in tenders.

Explore sectors
📋

Frequent CPV Codes

Review the most used CPV codes in the tenders this company has won.

View CPV codes
⚔️

Direct Competition

Analyze other bidding companies in the same sector to understand the competitive landscape.

View competition
📈

Market Trends

Stay up to date with the latest trends in public procurement and emerging opportunities.

View trends